Health Law Daily Wrap Up, CONTROLLED SUBSTANCES—PROPOSED RULES: DEA moves to temporarily classify 2-FDCK as a schedule I drug, (Jan 21, 2026)

By WK Editorial Staff

The DEA plans to temporarily classify 2 FDCK as a Schedule I drug.

The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one (commonly known as 2-fluorodeschloroketamine or 2-FDCK), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle 2-fluorodeschloroketamine (Proposed Rule, 91 Fed. Reg. 2323 (Jan. 20, 2026)).

Dates. January 20, 2026.

FederalRegisterIssuances: ProposedRules ControlledNews DrugBiologicNews